Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein - PubMed (original) (raw)

Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein

X Wu et al. J Virol. 1994 Oct.

Abstract

Viral protein X (Vpx) is a human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus accessory protein that is packaged into virions in molar amounts equivalent to Gag proteins. To delineate the processes of virus assembly that mediate Vpx packaging, we used a recombinant vaccinia virus-T7 RNA polymerase system to facilitate Gag protein expression, particle assembly, and extracellular release. HIV genes were placed under control of the bacteriophage T7 promoter and transfected into HeLa cells expressing T7 RNA polymerase. Western immunoblot analysis detected p55gag and its cleavage products p39 and p27 in purified particles derived by expression of gag and gag-pol, respectively. In trans expression of vpx with either HIV-2 gag or gag-pol gave rise to virus-like particles that contained Vpx in amounts similar to that detected in HIV-2 virus produced from productively infected T cells. Using C-terminal deletion and truncation mutants of HIV-2 Gag, we mapped the p15 coding sequence for determinants of Vpx packaging. This analysis revealed a region (residues 439 to 497) downstream of the nucleocapsid protein (NC) required for incorporation of Vpx into virions. HIV-1/HIV-2 gag chimeras were constructed to further characterize the requirements for incorporation of Vpx into virions. Chimeric HIV-1/HIV-2 Gag particles consisting of HIV-1 p17 and p24 fused in frame at the C terminus with HIV-2 p15 effectively incorporate Vpx, while chimeric HIV-2/HIV-1 Gag particles consisting of HIV-2 p17 and p27 fused in frame at the C terminus with HIV-1 p15 do not. Expression of a 68-amino-acid sequence of HIV-2 containing residues 439 to 497 fused to the coding regions of HIV-1 p17 and p24 also produced virus-like particles capable of packaging Vpx in amounts similar to that of full-length HIV-2 Gag. Sucrose gradient analysis confirmed particle association of Vpx and Gag proteins. These results demonstrate that the HIV-2 Gag precursor (p55) regulates incorporation of Vpx into virions and indicates that the packaging signal is located within residues 439 to 497.

PubMed Disclaimer

Similar articles

• Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.
  Wu X, Liu H, Xiao H, Kim J, Seshaiah P, Natsoulis G, Boeke JD, Hahn BH, Kappes JC. Wu X, et al. J Virol. 1995 Jun;69(6):3389-98. doi: 10.1128/JVI.69.6.3389-3398.1995. J Virol. 1995. PMID: 7745685 Free PMC article.
• Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.
  Wu X, Liu H, Xiao H, Conway JA, Kappes JC. Wu X, et al. J Virol. 1996 Jun;70(6):3378-84. doi: 10.1128/JVI.70.6.3378-3384.1996. J Virol. 1996. PMID: 8648668 Free PMC article.
• HIV-2 viral protein X association with the GAG p27 capsid protein.
  Horton R, Spearman P, Ratner L. Horton R, et al. Virology. 1994 Mar;199(2):453-7. doi: 10.1006/viro.1994.1144. Virology. 1994. PMID: 8122374
• Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components.
  Kappes JC, Parkin JS, Conway JA, Kim J, Brouillette CG, Shaw GM, Hahn BH. Kappes JC, et al. Virology. 1993 Mar;193(1):222-33. doi: 10.1006/viro.1993.1118. Virology. 1993. PMID: 8438567
• [Study of molecular function of proteins in human immunodeficiency virus].
  Fujita M. Fujita M. Yakugaku Zasshi. 2013;133(10):1103-11. doi: 10.1248/yakushi.13-00200. Yakugaku Zasshi. 2013. PMID: 24088354 Review. Japanese.

Cited by

• Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly.
  Wang H, Guo H, Su J, Rui Y, Zheng W, Gao W, Zhang W, Li Z, Liu G, Markham RB, Wei W, Yu XF. Wang H, et al. J Virol. 2017 Apr 13;91(9):e00225-17. doi: 10.1128/JVI.00225-17. Print 2017 May 1. J Virol. 2017. PMID: 28202763 Free PMC article.
• Degradation of SAMHD1 by Vpx Is Independent of Uncoating.
  Jáuregui P, Logue EC, Schultz ML, Fung S, Landau NR. Jáuregui P, et al. J Virol. 2015 May;89(10):5701-13. doi: 10.1128/JVI.03575-14. Epub 2015 Mar 11. J Virol. 2015. PMID: 25762741 Free PMC article.
• Nonstructural protein 5A is incorporated into hepatitis C virus low-density particle through interaction with core protein and microtubules during intracellular transport.
  Lai CK, Saxena V, Tseng CH, Jeng KS, Kohara M, Lai MM. Lai CK, et al. PLoS One. 2014 Jun 6;9(6):e99022. doi: 10.1371/journal.pone.0099022. eCollection 2014. PLoS One. 2014. PMID: 24905011 Free PMC article.
• New insights into an X-traordinary viral protein.
  Schaller T, Bauby H, Hué S, Malim MH, Goujon C. Schaller T, et al. Front Microbiol. 2014 Apr 8;5:126. doi: 10.3389/fmicb.2014.00126. eCollection 2014. Front Microbiol. 2014. PMID: 24782834 Free PMC article. Review.
• Variation of two primate lineage-specific residues in human SAMHD1 confers resistance to N terminus-targeted SIV Vpx proteins.
  Wei W, Guo H, Gao Q, Markham R, Yu XF. Wei W, et al. J Virol. 2014 Jan;88(1):583-91. doi: 10.1128/JVI.02866-13. Epub 2013 Oct 30. J Virol. 2014. PMID: 24173216 Free PMC article.

References

1. 1. Virology. 1990 Mar;175(1):139-48 - PubMed
2. 1. J Virol. 1989 Sep;63(9):4110-4 - PubMed
3. 1. Cell. 1989 Oct 6;59(1):103-12 - PubMed
4. 1. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8964-7 - PubMed
5. 1. EMBO J. 1989 Sep;8(9):2653-60 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database